78 related articles for article (PubMed ID: 23008099)
1. Lack of enantioselectivity in the SULT1A3-catalyzed sulfoconjugation of normetanephrine enantiomers: an in vitro and computational study.
Grouzmann E; Gualtierotti JB; Gerber-Lemaire S; Abid K; Brakch N; Pedretti A; Testa B; Vistoli G
Chirality; 2013 Jan; 25(1):28-34. PubMed ID: 23008099
[TBL] [Abstract][Full Text] [Related]
2. Regioselective sulfonation of dopamine by SULT1A3 in vitro provides a molecular explanation for the preponderance of dopamine-3-O-sulfate in human blood circulation.
Itäaho K; Alakurtti S; Yli-Kauhaluoma J; Taskinen J; Coughtrie MW; Kostiainen R
Biochem Pharmacol; 2007 Aug; 74(3):504-10. PubMed ID: 17548063
[TBL] [Abstract][Full Text] [Related]
3. Effects of human SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of acetaminophen and opioid drugs by the cytosolic sulfotransferase SULT1A3.
Bairam AF; Rasool MI; Alherz FA; Abunnaja MS; El Daibani AA; Kurogi K; Liu MC
Arch Biochem Biophys; 2018 Jun; 648():44-52. PubMed ID: 29705271
[TBL] [Abstract][Full Text] [Related]
4. X-ray crystal structure of human dopamine sulfotransferase, SULT1A3. Molecular modeling and quantitative structure-activity relationship analysis demonstrate a molecular basis for sulfotransferase substrate specificity.
Dajani R; Cleasby A; Neu M; Wonacott AJ; Jhoti H; Hood AM; Modi S; Hersey A; Taskinen J; Cooke RM; Manchee GR; Coughtrie MW
J Biol Chem; 1999 Dec; 274(53):37862-8. PubMed ID: 10608851
[TBL] [Abstract][Full Text] [Related]
5. Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity.
Toth D; Dudas B; Miteva MA; Balog E
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069221
[TBL] [Abstract][Full Text] [Related]
6. Tetrahydrobiopterin regulates monoamine neurotransmitter sulfonation.
Cook I; Wang T; Leyh TS
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):E5317-E5324. PubMed ID: 28630292
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of human catecholamine sulfotransferase.
Bidwell LM; McManus ME; Gaedigk A; Kakuta Y; Negishi M; Pedersen L; Martin JL
J Mol Biol; 1999 Oct; 293(3):521-30. PubMed ID: 10543947
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of human sulfotransferase SULT1A3 in complex with dopamine and 3'-phosphoadenosine 5'-phosphate.
Lu JH; Li HT; Liu MC; Zhang JP; Li M; An XM; Chang WR
Biochem Biophys Res Commun; 2005 Sep; 335(2):417-23. PubMed ID: 16083857
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the substrate specificity of human sulfotransferases SULT1A1 and SULT1A3: site-directed mutagenesis and kinetic studies.
Brix LA; Barnett AC; Duggleby RG; Leggett B; McManus ME
Biochemistry; 1999 Aug; 38(32):10474-9. PubMed ID: 10441143
[TBL] [Abstract][Full Text] [Related]
10. A single amino acid, glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3.
Dajani R; Hood AM; Coughtrie MW
Mol Pharmacol; 1998 Dec; 54(6):942-8. PubMed ID: 9855620
[TBL] [Abstract][Full Text] [Related]
11. Investigation on the enantioselectivity of the sulfation of the methylenedioxymethamphetamine metabolites 3,4-dihydroxymethamphetamine and 4-hydroxy-3-methoxymethamphetamine using the substrate-depletion approach.
Schwaninger AE; Meyer MR; Maurer HH
Drug Metab Dispos; 2011 Nov; 39(11):1998-2002. PubMed ID: 21795466
[TBL] [Abstract][Full Text] [Related]
12. Spectrofluorometric assay for monoamine-preferring phenol sulfotransferase (SULT1A3).
Lu LY; Hsu YC; Yang YS
Anal Biochem; 2010 Sep; 404(2):241-3. PubMed ID: 20566371
[TBL] [Abstract][Full Text] [Related]
13. Sulfation of ritodrine by the human cytosolic sulfotransferases (SULTs): Effects of SULT1A3 genetic polymorphism.
Hui Y; Liu MC
Eur J Pharmacol; 2015 Aug; 761():125-9. PubMed ID: 25941087
[TBL] [Abstract][Full Text] [Related]
14. Sulfation of catecholamines and serotonin by SULT1A3 allozymes.
Bairam AF; Rasool MI; Alherz FA; Abunnaja MS; El Daibani AA; Gohal SA; Kurogi K; Sakakibara Y; Suiko M; Liu MC
Biochem Pharmacol; 2018 May; 151():104-113. PubMed ID: 29524394
[TBL] [Abstract][Full Text] [Related]
15. Small-molecule control of neurotransmitter sulfonation.
Cook I; Cacace M; Wang T; Darrah K; Deiters A; Leyh TS
J Biol Chem; 2021; 296():100094. PubMed ID: 33485192
[TBL] [Abstract][Full Text] [Related]
16. CoMFA modeling of enzyme kinetics: K(m) values for sulfation of diverse phenolic substrates by human catecholamine sulfotransferase SULT1A3.
Sipilä J; Hood AM; Coughtrie MW; Taskinen J
J Chem Inf Comput Sci; 2003; 43(5):1563-9. PubMed ID: 14502490
[TBL] [Abstract][Full Text] [Related]
17. Impact of SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of phenylephrine and salbutamol by human SULT1A3 allozymes.
Bairam AF; Rasool MI; Alherz FA; Abunnaja MS; El Daibani AA; Gohal SA; Alatwi ES; Kurogi K; Liu MC
Pharmacogenet Genomics; 2019 Jul; 29(5):99-105. PubMed ID: 31145702
[TBL] [Abstract][Full Text] [Related]
18. Kinetic properties of human dopamine sulfotransferase (SULT1A3) expressed in prokaryotic and eukaryotic systems: comparison with the recombinant enzyme purified from Escherichia coli.
Dajani R; Sharp S; Graham S; Bethell SS; Cooke RM; Jamieson DJ; Coughtrie MW
Protein Expr Purif; 1999 Jun; 16(1):11-8. PubMed ID: 10336855
[TBL] [Abstract][Full Text] [Related]
19. Benzylic alcohols as stereospecific substrates and inhibitors for aryl sulfotransferase.
Rao SI; Duffel MW
Chirality; 1991; 3(2):104-11. PubMed ID: 1863522
[TBL] [Abstract][Full Text] [Related]
20. Human cytosolic sulfotransferase SULT1A1.
Hempel N; Gamage N; Martin JL; McManus ME
Int J Biochem Cell Biol; 2007; 39(4):685-9. PubMed ID: 17110154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
